Universe Pharmaceuticals Stock Analysis

Universe Stock Analysis Notes

About 57.0% of the company outstanding shares are owned by insiders. The company has Price to Book (P/B) ratio of 0.16. Historically many companies with similar price-to-book (P/B) ratio do better than the market in the long run. Universe Pharmaceuticals recorded a loss per share of 1.7. The entity had not issued any dividends in recent years. The firm had 1:6 split on the 28th of July 2023. Universe Pharmaceuticals INC, a pharmaceutical company, engages in the manufacture, marketing, distribution, and sale of traditional Chinese medicine derivative products in China. Universe Pharmaceuticals INC is a subsidiary of Sununion Holding Group Limited. Universe Pharmaceuticals is traded on NASDAQ Exchange in the United States. For more information please call Gang Lai at 86 79 6840 3309 or visit https://www.universe-pharmacy.com.

Universe Pharmaceuticals Investment Alerts

Universe Pharmaceuticals Upcoming and Recent Events

Universe Stock Institutional Investors

Note, although Universe Pharmaceuticals' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Universe Market Capitalization

The company currently falls under 'Nano-Cap' category with a total capitalization of 7.98 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Universe Pharmaceuticals's market, we take the total number of its shares issued and multiply it by Universe Pharmaceuticals's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Universe Profitablity

The company has Net Profit Margin of (0.19) %, which means that it does not effectively control expenditures or properly executes on its pricing strategies. This is way below average. In the same way, it shows Net Operating Margin of (0.27) %, which entails that for every $100 of revenue, it lost $0.27.

Management Efficiency

Universe Pharmaceuticals has Return on Asset of (0.0391) % which means that on every $100 spent on assets, it lost $0.0391. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of (0.1434) %, meaning that it generated no profit with money invested by stockholders. Universe Pharmaceuticals' management efficiency ratios could be used to measure how well Universe Pharmaceuticals manages its routine affairs as well as how well it operates its assets and liabilities. As of April 19, 2024, Return On Tangible Assets is expected to decline to -0.13. The current year's Return On Capital Employed is expected to grow to -0.1. At present, Universe Pharmaceuticals' Intangible Assets are projected to decrease significantly based on the last few years of reporting. The current year's Intangibles To Total Assets is expected to grow to 0.01, whereas Total Assets are forecasted to decline to about 47.2 M.

Technical Drivers

As of the 19th of April, Universe Pharmaceuticals has the Coefficient Of Variation of 3258.77, risk adjusted performance of 0.0285, and Semi Deviation of 10.55. In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Universe Pharmaceuticals, as well as the relationship between them. In other words, you can use this information to find out if the company will indeed mirror its model of past prices and volume data, or the prices will eventually revert. We were able to interpolate data for nineteen technical drivers for Universe Pharmaceuticals, which can be compared to its competition. Please validate Universe Pharmaceuticals jensen alpha, as well as the relationship between the potential upside and skewness to decide if Universe Pharmaceuticals is priced more or less accurately, providing market reflects its prevalent price of 2.19 per share. Please also confirm Universe Pharmaceuticals total risk alpha, which is currently at (0.78) to double-check the company can sustain itself at a future point.

Universe Pharmaceuticals Price Movement Analysis

Universe Pharmaceuticals Predictive Daily Indicators

Universe Pharmaceuticals Corporate Filings

Universe Pharmaceuticals Forecast Models

Universe Pharmaceuticals' time-series forecasting models are one of many Universe Pharmaceuticals' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Universe Pharmaceuticals' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Universe Pharmaceuticals prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Universe shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Universe Pharmaceuticals. By using and applying Universe Stock analysis, traders can create a robust methodology for identifying Universe entry and exit points for their positions.

Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Universe Pharmaceuticals. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in american community survey. For information on how to trade Universe Stock refer to our How to Trade Universe Stock guide.You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.

When running Universe Pharmaceuticals' price analysis, check to measure Universe Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Universe Pharmaceuticals is operating at the current time. Most of Universe Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Universe Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Universe Pharmaceuticals' price. Additionally, you may evaluate how the addition of Universe Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.

Is Universe Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Universe Pharmaceuticals. If investors know Universe will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Universe Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

The market value of Universe Pharmaceuticals is measured differently than its book value, which is the value of Universe that is recorded on the company's balance sheet. Investors also form their own opinion of Universe Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Universe Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Universe Pharmaceuticals' market value can be influenced by many factors that don't directly affect Universe Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Universe Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Universe Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Universe Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.